Cell Therapy Industry Report 2022

An overview of the global cell therapy landscape

Download the report and...

• Learn how the cell therapy funding landscape has grown over the years, with a focus on deals and investments made in 2021 and 2022.
• Discover some of the key players involved in the cell therapy space and the products available on the market.
• Find out what cell therapy entails by learning about how treatments are categorized and which medical fields are harnessing this technology.
• Discover the future of cell therapy and which new indications are being targeted by researchers, from HIV to autoimmune diseases.

About this report

By 2028, the value of the global cell therapy market is projected to surpass $45B, up from less than $20B in 2020. Some industry insiders even anticipate that cell and gene therapies will overtake conventional drug therapies in the not-so-distant future, with sales projected to significantly increase by 2026.

This report gives an overview of the global cell therapy landscape, highlighting several players in the space; key licensing deals and investments; and the effect of the Covid-19 pandemic on the industry. It also takes a closer look at what cell therapy entails, from delineating the different subtypes to the different medical fields employing cell therapies. A particular focus is placed on adoptive cell therapies, including CAR-T cell therapy, which have seen a major influx in interest in the previous years.